Industries

This study examines how healthcare organizations are advancing their cloud strategies amid rising demand for AI, increased financial pressures, and growing operational complexity. Findings show that the cloud has become the core foundation of digital transformation, with adoption shifting from basic migration toward modernization, automation, and A...

The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, artificial intelligence (AI)-based solutions and diagnostics industry. The issue includes advanced medical devices such as spinal cord stimulation, Bluetooth-enabled transcutaneous continuous glucose monit...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

The "Top 10 Global Trends for 2026” report highlights the technological, geopolitical, and economic forces that will redefine the future of industries. The report covers the top trends that will transform the industries in 2026 and beyond.Some of the trends included are tariff-driven market shifts, hyper-connected reality, ethical use of AI, and ne...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...

The MedTech industry until 2040 encompasses groundbreaking integrations of artificial intelligence (AI), biotechnology, regenerative therapies, nanomedicine, and sustainable digital ecosystems to redefine preventive, personalized, and precision healthcare. These advancements enable real-time genomic editing, implantable biosensors for continuous mo...